Megakaryocytes (MKs) are responsible for the production of platelets, which have a major impact on blood homeostasis. MK is unique among blood cells in attaining states of polyploidy, which precedes platelet biogenesis. Uncontrolled MK proliferation and deregulated polyploidization are hallmarks of some blood cell pathologies. Our recent studies implicate Lysyl Oxidase (LOX) in the regulation of MK ploidy and proliferation. This revised competitive renewal application investigates the role of LOX in these processes. LOX is a known extracellular regulator of the fibrogenic response, acting by cross-linking matrix proteins. Although the role growth factors released by MK, such as Platelet-Derived Growth Factor-ss (PDGF-ss), has been documented in the expansion of the MK lineage in MK leukemia-associated myelofibrosis, many aspects of this condition remain elusive, and current treatments are largely ineffective. Our preliminary findings indicate that LOX is expressed at low levels in a pool of normal MKs, primarily in the low-ploidy cells. However, LOX is abundant in displastic MKs associated with myelofibrosis, and is upregulated by PDGF-ss. We found that inhibition of LOX enzyme activity significantly diminished PDGF-ss binding to cells and PDGF-ss-induced expansion of MKs. We also made the novel observation that LOX-PP, a product of pre- LOX processing, inhibits MK polyploidization. Based on these findings, we hypothesize that upregulated LOX in displastic or leukemic MKs has a pivotal role in MK expansion, inhibition of polyploidy, and matrix deposition. To test this, we propose three specific aims: 1. Elucidate the mechanism of effect of LOX-PP on MK polyploidization; 2. Investigate the mechanism of effect of LOX on PDGF-ss-induced MK expansion; and 3. Determine the consequences of altered LOX expression in vivo on MK expansion, polyploidy and myelofibrosis. Understanding how LOX and LOX-PP regulates MK proliferation and polyploidization will identify new targets for control of these processes, informing the development of new therapeutic interventions for MK-related disorders and providing further insight into the physiological control of MK ploidy and proliferation.

Public Health Relevance

Megakaryocytes (MKs) are responsible for the production of platelets, which have a major impact on blood homeostasis. MKs is unique among blood cells in attaining states of polyploidy, which precedes platelet biogenesis. Uncontrolled MK proliferation and deregulated polyploidization are hallmarks of blood cells pathology, and this research proposal focuses on novel aspects of regulation of MK expansion and polyploidization, involving Lysyl Oxidase (LOX) as a newly identified regulator of these processes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL080442-09
Application #
8823809
Study Section
Molecular and Cellular Hematology Study Section (MCH)
Program Officer
Sarkar, Rita
Project Start
2005-03-01
Project End
2017-03-31
Budget Start
2015-04-01
Budget End
2017-03-31
Support Year
9
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Boston University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
Leiva, Orly; Leon, Catherine; Kah Ng, Seng et al. (2018) The role of extracellular matrix stiffness in megakaryocyte and platelet development and function. Am J Hematol 93:430-441
Kolachalama, Vijaya B; Shashar, Moshe; Alousi, Faisal et al. (2018) Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans. J Am Soc Nephrol 29:1063-1072
Abbonante, Vittorio; Chitalia, Vipul; Rosti, Vittorio et al. (2017) Upregulation of lysyl oxidase and adhesion to collagen of human megakaryocytes and platelets in primary myelofibrosis. Blood 130:829-831
Abbonante, Vittorio; Di Buduo, Christian Andrea; Gruppi, Cristian et al. (2017) A new path to platelet production through matrix sensing. Haematologica 102:1150-1160
Shashar, Moshe; Belghasem, Mostafa E; Matsuura, Shinobu et al. (2017) Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk. Sci Transl Med 9:
Leiva, O; Ng, S K; Chitalia, S et al. (2017) The role of the extracellular matrix in primary myelofibrosis. Blood Cancer J 7:e525
Lucero, Hector A; Patterson, Shenia; Matsuura, Shinobu et al. (2016) Quantitative histological image analyses of reticulin fibers in a myelofibrotic mouse. J Biol Methods 3:
Matsuura, S; Patterson, S; Lucero, H et al. (2016) In vivo magnetic resonance imaging of a mouse model of myelofibrosis. Blood Cancer J 6:e497
Matsuura, Shinobu; Mi, Rongjuan; Koupenova, Milka et al. (2016) Lysyl oxidase is associated with increased thrombosis and platelet reactivity. Blood 127:1493-501
Jing, Lili; Tamplin, Owen J; Chen, Michael J et al. (2015) Adenosine signaling promotes hematopoietic stem and progenitor cell emergence. J Exp Med 212:649-63

Showing the most recent 10 out of 23 publications